Monsenso AS

Research Monsenso AS (MONSO) on Bullrun: market cap DKK 20.03M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerMONSO
ExchangeCO
CountryDenmark
SectorHealthcare
IndustryHealth Information Services
CurrencyDKK
Market capDKK 20.03M
Financial periodFY2025
RevenueDKK 8.91M
Revenue growth-20.2%
Net income-DKK 7.22M
Free cash flow-DKK 3.63M
Gross margin40.5%

Valuation Snapshot

latest market cap is DKK 20.03M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	DKK 8.91M	-DKK 7.22M	-DKK 3.63M	40.5%	n/a	DKK 54.00K	DKK 1.84M	DKK 6.98M
FY2024	DKK 11.17M	-DKK 6.00M	-DKK 9.36M	44.6%	-0.12	DKK 1.86M	DKK 0	DKK 14.16M
FY2023	DKK 9.62M	-DKK 5.36M	-DKK 235.00K	47.1%	-0.19	DKK 1.81M	n/a	DKK 10.87M
FY2022	DKK 6.21M	-DKK 7.85M	-DKK 8.39M	51.5%	-0.3	DKK 572.00K	n/a	DKK 14.76M
FY2021	n/a	n/a	n/a	n/a	-0.57	n/a	n/a	n/a

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-23	DKK 20.03M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 DKK.

About Monsenso AS

Monsenso A/S develops and sells digital health solution for the treatment of depression, bipolar disorder, anxiety, schizophrenia, borderline personality disorder, and addiction and substance abuse in Denmark. The company offers Monsenso app for individuals that collects patient-reported and sensor data providing insights into symptoms, adherence, and outcomes.

Related stock research

Denmark stocks Denmark Healthcare stocks A-Z stock index

Other Healthcare stocks

Strategic Partners A/S (1TB0) 2cureX AB (2CUREX) CESSATECH A/S DK -20 (8GN) FLUOGUIDE A/S DK -1 (96X) ALK-Abelló A/S (ALK-B) Ambu A/S (AMBU-B) Ascendis Pharma A/S (ASND) BioPorto (BIOPOR) Bavarian Nordic A/S (BV3A) Coloplast A/S (CBHD) ChemoMetec A/S (CHEMM) Demant A/S (DEMANT)

Frequently asked questions

What is Monsenso AS's market cap?

Monsenso AS's market capitalization is DKK 20.03M.